14 research outputs found
Churg-Strauss syndrome associated with AA amyloidosis: a case report
Churg Strauss syndrome is a rare systemic and pulmonary vasculitis exceptionally associated with AA amyloidosis. We report the case of a 65-year old woman with past medical history of asthma. She developed polyarthralgia, headache and purpura. A laboratory workout found hypereosinophilia (1150/μL), positive p-ANCA, microscopic haematuria and proteinuria at 2g/day. A diagnosis of Churg-Strauss syndrome was established based on five criteria of the American College of Rheumatology (ACR). Renal biopsy showed an important type AA amyloid deposit. The patient was treated with steroids with a good response of the vasculitis and amyloidosis with disappearance of the proteinuria.Pan African Medical Journal 2012; 12:3
Conduite à tenir devant la découverte d’une gammapathie monoclonale à l’électrophorèse des protéines
La découverte d’un pic monoclonal lors d’une électrophorèse des protéines sanguines impose de réaliser un bilan biologique et radiologique afin d’éliminer en priorité une hémopathie maligne. Lorsque ce bilan complémentaire est négatif, on parle alors de gammapathie monoclonale de signification indéterminée (GMSI). Le diagnostic de GMSI implique une surveillance régulière afin d’identifier précocement les signes de transformation maligne
PB2568: BIERMER’S DISEASE REVEALED BY SPONTANEOUS ABORTIONS AND IRON DEFICIENCY ANEMIA: A CASE REPORT.
PB2557: CHARACTERISTICS OF AUTOIMMUNE HEMOLYTIC ANEMIA IN ADULTS: A CASE SERIES OF 35 PATIENTS
Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with a high female predominance. To date, studies about SLE in Morocco are few. This retrospective study describes the clinical and immunological features in a series of 50 SLE Moroccan patients in University Hospital Center of Rabat, Morocco, between December 2011 and December 2013. All patients were screened for antinuclear antibodies (ANA) and anti-DNA antibodies by indirect immunofluorescence, followed by identification of anti-extractable nuclear antigen antibodies by ELISA. The female to male ratio was 6.1:1. Mean age was 31.72 years. The main clinical manifestations were arthritis (82%), mucocutaneous manifestations (80%), renal manifestations (50%), and hematological features (46%). Of the mucocutaneous features, the highest frequencies were observed in the malar rash (68%) and photosensitivity (60%). Of the hematological features, lymphopenia was most frequently observed in 30% of patients, followed by hemolytic anemia in 16% and leucopenia and thrombocytopenia in 8%. Central nervous system was involved in 10%. ANA were found in 88%, anti-DNA antibodies in 56%, and anti-Sm antibodies in 50%. Anti-SSA, anti-SSB, anti-Sm/RNP, and anti-Scl70 antibodies were detected in 38%, 10%, 48%, and 8%, respectively. Our data show that, in our patients, the main clinical and immunological features of SLE remain comparable to patients from other Arab countries